0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Osteoarthritis Pain Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Auto-1556
Home | Market Reports | Health | Health Conditions | Pain Management
Global Osteoarthritis Pain Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Osteoarthritis Pain Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Auto-1556
Report
July 2021
144 Pages
QYResearch
Region: North America, Asia-PacificEurope, Central & South AmericaRest of Central & South America, Middle East & Africa, Global, Europe,
Description
Table of Content
Tables & Figures
The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis, osteoarthritis in the use of two kinds of painkillers.
The major players in global Methylcyclohexane market include Pfizer, Johnson & Johnson, GlaxoSmithKline, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Oral is the main type, with a share over 50%. Personal Care is the main application, which holds a share about 90%.
Market Analysis and Insights: Global Osteoarthritis Pain Drugs Market

In 2020, the global Osteoarthritis Pain Drugs market size was US$ 9238 million and it is expected to reach US$ 13690 million by the end of 2027, with a CAGR of 5.7% during 2021-2027.

Global Osteoarthritis Pain Drugs Scope and Market Size
Osteoarthritis Pain Drugs market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Osteoarthritis Pain Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Osteoarthritis Pain Drugs market is segmented into

Oral
Injection
External

Segment by Application, the Osteoarthritis Pain Drugs market is segmented into

Medical Care
Personal Care
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape and Osteoarthritis Pain Drugs Market Share Analysis
Osteoarthritis Pain Drugs market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Osteoarthritis Pain Drugs product introduction, recent developments, Osteoarthritis Pain Drugs sales by region, type, application and by sales channel.
The major companies include:
Pfizer
Bayer
SK Chemicals
GSK
Sanofi
Crystal Genomics
Johnson & Johnson
Sino Biopharmaceutical
Haohai Biological
Zhejiang Chengyi Pharmaceutical
Freda
Bright Future
Jingfeng Pharmaceutical
Chugai Pharmaceutical
Mikasa Seiyaku
Taisho Pharmaceutical
Seikagaku Corporation
GlaxoSmithKline
Eli Lilly
Novartis
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
1 Study Coverage
1.1 Osteoarthritis Pain Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Type
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Application
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Osteoarthritis Pain Drugs Market Size Estimates and Forecasts
2.1.1 Global Osteoarthritis Pain Drugs Revenue 2016-2027
2.1.2 Global Osteoarthritis Pain Drugs Sales 2016-2027
2.2 Osteoarthritis Pain Drugs Market Size by Region: 2021 Versus 2027
2.3 Osteoarthritis Pain Drugs Sales by Region (2016-2027)
2.3.1 Global Osteoarthritis Pain Drugs Sales by Region: 2016-2021
2.3.2 Global Osteoarthritis Pain Drugs Sales Forecast by Region (2022-2027)
2.3.3 Global Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2027)
2.4 Osteoarthritis Pain Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Osteoarthritis Pain Drugs Revenue by Region: 2016-2021
2.4.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Region (2022-2027)
2.4.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2016-2027)
3 Global Osteoarthritis Pain Drugs by Manufacturers
3.1 Global Top Osteoarthritis Pain Drugs Manufacturers by Sales
3.1.1 Global Osteoarthritis Pain Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Osteoarthritis Pain Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Osteoarthritis Pain Drugs Manufacturers by Revenue
3.2.1 Global Osteoarthritis Pain Drugs Revenue by Manufacturer (2016-2021)
3.2.2 Global Osteoarthritis Pain Drugs Revenue Share by Manufacturer (2016-2021)
3.3 Global Osteoarthritis Pain Drugs Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Osteoarthritis Pain Drugs Manufacturers Covered: Ranking by Revenue
3.4.2 Global Osteoarthritis Pain Drugs Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Osteoarthritis Pain Drugs Manufacturing Base Distribution, Product Type
3.5.1 Osteoarthritis Pain Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Osteoarthritis Pain Drugs Product Type
3.5.3 Date of International Manufacturers Enter into Osteoarthritis Pain Drugs Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Pfizer
4.1.1 Pfizer Corporation Information
4.1.2 Pfizer Description, Business Overview
4.1.3 Pfizer Osteoarthritis Pain Drugs Products Offered
4.1.4 Pfizer Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Pfizer Osteoarthritis Pain Drugs Revenue by Product
4.1.6 Pfizer Osteoarthritis Pain Drugs Revenue by Application
4.1.7 Pfizer Osteoarthritis Pain Drugs Revenue by Geographic Area
4.1.8 Pfizer Osteoarthritis Pain Drugs Revenue by Sales Channel
4.1.9 Pfizer Recent Development
4.2 Bayer
4.2.1 Bayer Corporation Information
4.2.2 Bayer Description, Business Overview
4.2.3 Bayer Osteoarthritis Pain Drugs Products Offered
4.2.4 Bayer Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Bayer Osteoarthritis Pain Drugs Revenue by Product
4.2.6 Bayer Osteoarthritis Pain Drugs Revenue by Application
4.2.7 Bayer Osteoarthritis Pain Drugs Revenue by Geographic Area
4.2.8 Bayer Osteoarthritis Pain Drugs Revenue by Sales Channel
4.2.9 Bayer Recent Development
4.3 SK Chemicals
4.3.1 SK Chemicals Corporation Information
4.3.2 SK Chemicals Description, Business Overview
4.3.3 SK Chemicals Osteoarthritis Pain Drugs Products Offered
4.3.4 SK Chemicals Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.3.5 SK Chemicals Osteoarthritis Pain Drugs Revenue by Product
4.3.6 SK Chemicals Osteoarthritis Pain Drugs Revenue by Application
4.3.7 SK Chemicals Osteoarthritis Pain Drugs Revenue by Geographic Area
4.3.8 SK Chemicals Osteoarthritis Pain Drugs Revenue by Sales Channel
4.3.9 SK Chemicals Recent Development
4.4 GSK
4.4.1 GSK Corporation Information
4.4.2 GSK Description, Business Overview
4.4.3 GSK Osteoarthritis Pain Drugs Products Offered
4.4.4 GSK Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.4.5 GSK Osteoarthritis Pain Drugs Revenue by Product
4.4.6 GSK Osteoarthritis Pain Drugs Revenue by Application
4.4.7 GSK Osteoarthritis Pain Drugs Revenue by Geographic Area
4.4.8 GSK Osteoarthritis Pain Drugs Revenue by Sales Channel
4.4.9 GSK Recent Development
4.5 Sanofi
4.5.1 Sanofi Corporation Information
4.5.2 Sanofi Description, Business Overview
4.5.3 Sanofi Osteoarthritis Pain Drugs Products Offered
4.5.4 Sanofi Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Sanofi Osteoarthritis Pain Drugs Revenue by Product
4.5.6 Sanofi Osteoarthritis Pain Drugs Revenue by Application
4.5.7 Sanofi Osteoarthritis Pain Drugs Revenue by Geographic Area
4.5.8 Sanofi Osteoarthritis Pain Drugs Revenue by Sales Channel
4.5.9 Sanofi Recent Development
4.6 Crystal Genomics
4.6.1 Crystal Genomics Corporation Information
4.6.2 Crystal Genomics Description, Business Overview
4.6.3 Crystal Genomics Osteoarthritis Pain Drugs Products Offered
4.6.4 Crystal Genomics Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Crystal Genomics Osteoarthritis Pain Drugs Revenue by Product
4.6.6 Crystal Genomics Osteoarthritis Pain Drugs Revenue by Application
4.6.7 Crystal Genomics Osteoarthritis Pain Drugs Revenue by Geographic Area
4.6.8 Crystal Genomics Recent Development
4.7 Johnson & Johnson
4.7.1 Johnson & Johnson Corporation Information
4.7.2 Johnson & Johnson Description, Business Overview
4.7.3 Johnson & Johnson Osteoarthritis Pain Drugs Products Offered
4.7.4 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Johnson & Johnson Osteoarthritis Pain Drugs Revenue by Product
4.7.6 Johnson & Johnson Osteoarthritis Pain Drugs Revenue by Application
4.7.7 Johnson & Johnson Osteoarthritis Pain Drugs Revenue by Geographic Area
4.7.8 Johnson & Johnson Recent Development
4.8 Sino Biopharmaceutical
4.8.1 Sino Biopharmaceutical Corporation Information
4.8.2 Sino Biopharmaceutical Description, Business Overview
4.8.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Products Offered
4.8.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Sino Biopharmaceutical Osteoarthritis Pain Drugs Revenue by Product
4.8.6 Sino Biopharmaceutical Osteoarthritis Pain Drugs Revenue by Application
4.8.7 Sino Biopharmaceutical Osteoarthritis Pain Drugs Revenue by Geographic Area
4.8.8 Sino Biopharmaceutical Recent Development
4.9 Haohai Biological
4.9.1 Haohai Biological Corporation Information
4.9.2 Haohai Biological Description, Business Overview
4.9.3 Haohai Biological Osteoarthritis Pain Drugs Products Offered
4.9.4 Haohai Biological Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.9.5 Haohai Biological Osteoarthritis Pain Drugs Revenue by Product
4.9.6 Haohai Biological Osteoarthritis Pain Drugs Revenue by Application
4.9.7 Haohai Biological Osteoarthritis Pain Drugs Revenue by Geographic Area
4.9.8 Haohai Biological Recent Development
4.10 Zhejiang Chengyi Pharmaceutical
4.10.1 Zhejiang Chengyi Pharmaceutical Corporation Information
4.10.2 Zhejiang Chengyi Pharmaceutical Description, Business Overview
4.10.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Products Offered
4.10.4 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Revenue by Product
4.10.6 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Revenue by Application
4.10.7 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Revenue by Geographic Area
4.10.8 Zhejiang Chengyi Pharmaceutical Recent Development
4.11 Freda
4.11.1 Freda Corporation Information
4.11.2 Freda Description, Business Overview
4.11.3 Freda Osteoarthritis Pain Drugs Products Offered
4.11.4 Freda Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Freda Osteoarthritis Pain Drugs Revenue by Product
4.11.6 Freda Osteoarthritis Pain Drugs Revenue by Application
4.11.7 Freda Osteoarthritis Pain Drugs Revenue by Geographic Area
4.11.8 Freda Recent Development
4.12 Bright Future
4.12.1 Bright Future Corporation Information
4.12.2 Bright Future Description, Business Overview
4.12.3 Bright Future Osteoarthritis Pain Drugs Products Offered
4.12.4 Bright Future Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.12.5 Bright Future Osteoarthritis Pain Drugs Revenue by Product
4.12.6 Bright Future Osteoarthritis Pain Drugs Revenue by Application
4.12.7 Bright Future Osteoarthritis Pain Drugs Revenue by Geographic Area
4.12.8 Bright Future Recent Development
4.13 Jingfeng Pharmaceutical
4.13.1 Jingfeng Pharmaceutical Corporation Information
4.13.2 Jingfeng Pharmaceutical Description, Business Overview
4.13.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Products Offered
4.13.4 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.13.5 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Revenue by Product
4.13.6 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Revenue by Application
4.13.7 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Revenue by Geographic Area
4.13.8 Jingfeng Pharmaceutical Recent Development
4.14 Chugai Pharmaceutical
4.14.1 Chugai Pharmaceutical Corporation Information
4.14.2 Chugai Pharmaceutical Description, Business Overview
4.14.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Products Offered
4.14.4 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.14.5 Chugai Pharmaceutical Osteoarthritis Pain Drugs Revenue by Product
4.14.6 Chugai Pharmaceutical Osteoarthritis Pain Drugs Revenue by Application
4.14.7 Chugai Pharmaceutical Osteoarthritis Pain Drugs Revenue by Geographic Area
4.14.8 Chugai Pharmaceutical Recent Development
4.15 Mikasa Seiyaku
4.15.1 Mikasa Seiyaku Corporation Information
4.15.2 Mikasa Seiyaku Description, Business Overview
4.15.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Products Offered
4.15.4 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.15.5 Mikasa Seiyaku Osteoarthritis Pain Drugs Revenue by Product
4.15.6 Mikasa Seiyaku Osteoarthritis Pain Drugs Revenue by Application
4.15.7 Mikasa Seiyaku Osteoarthritis Pain Drugs Revenue by Geographic Area
4.15.8 Mikasa Seiyaku Recent Development
4.16 Taisho Pharmaceutical
4.16.1 Taisho Pharmaceutical Corporation Information
4.16.2 Taisho Pharmaceutical Description, Business Overview
4.16.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Products Offered
4.16.4 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.16.5 Taisho Pharmaceutical Osteoarthritis Pain Drugs Revenue by Product
4.16.6 Taisho Pharmaceutical Osteoarthritis Pain Drugs Revenue by Application
4.16.7 Taisho Pharmaceutical Osteoarthritis Pain Drugs Revenue by Geographic Area
4.16.8 Taisho Pharmaceutical Recent Development
4.17 Seikagaku Corporation
4.17.1 Seikagaku Corporation Corporation Information
4.17.2 Seikagaku Corporation Description, Business Overview
4.17.3 Seikagaku Corporation Osteoarthritis Pain Drugs Products Offered
4.17.4 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.17.5 Seikagaku Corporation Osteoarthritis Pain Drugs Revenue by Product
4.17.6 Seikagaku Corporation Osteoarthritis Pain Drugs Revenue by Application
4.17.7 Seikagaku Corporation Osteoarthritis Pain Drugs Revenue by Geographic Area
4.17.8 Seikagaku Corporation Recent Development
4.18 GlaxoSmithKline
4.18.1 GlaxoSmithKline Corporation Information
4.18.2 GlaxoSmithKline Description, Business Overview
4.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Products Offered
4.18.4 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.18.5 GlaxoSmithKline Osteoarthritis Pain Drugs Revenue by Product
4.18.6 GlaxoSmithKline Osteoarthritis Pain Drugs Revenue by Application
4.18.7 GlaxoSmithKline Osteoarthritis Pain Drugs Revenue by Geographic Area
4.18.8 GlaxoSmithKline Recent Development
4.19 Eli Lilly
4.19.1 Eli Lilly Corporation Information
4.19.2 Eli Lilly Description, Business Overview
4.19.3 Eli Lilly Osteoarthritis Pain Drugs Products Offered
4.19.4 Eli Lilly Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.19.5 Eli Lilly Osteoarthritis Pain Drugs Revenue by Product
4.19.6 Eli Lilly Osteoarthritis Pain Drugs Revenue by Application
4.19.7 Eli Lilly Osteoarthritis Pain Drugs Revenue by Geographic Area
4.19.8 Eli Lilly Recent Development
4.20 Novartis
4.20.1 Novartis Corporation Information
4.20.2 Novartis Description, Business Overview
4.20.3 Novartis Osteoarthritis Pain Drugs Products Offered
4.20.4 Novartis Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.20.5 Novartis Osteoarthritis Pain Drugs Revenue by Product
4.20.6 Novartis Osteoarthritis Pain Drugs Revenue by Application
4.20.7 Novartis Osteoarthritis Pain Drugs Revenue by Geographic Area
4.20.8 Novartis Recent Development
4.21 Horizon Pharma
4.21.1 Horizon Pharma Corporation Information
4.21.2 Horizon Pharma Description, Business Overview
4.21.3 Horizon Pharma Osteoarthritis Pain Drugs Products Offered
4.21.4 Horizon Pharma Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.21.5 Horizon Pharma Osteoarthritis Pain Drugs Revenue by Product
4.21.6 Horizon Pharma Osteoarthritis Pain Drugs Revenue by Application
4.21.7 Horizon Pharma Osteoarthritis Pain Drugs Revenue by Geographic Area
4.21.8 Horizon Pharma Recent Development
4.22 Abbott
4.22.1 Abbott Corporation Information
4.22.2 Abbott Description, Business Overview
4.22.3 Abbott Osteoarthritis Pain Drugs Products Offered
4.22.4 Abbott Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.22.5 Abbott Osteoarthritis Pain Drugs Revenue by Product
4.22.6 Abbott Osteoarthritis Pain Drugs Revenue by Application
4.22.7 Abbott Osteoarthritis Pain Drugs Revenue by Geographic Area
4.22.8 Abbott Recent Development
4.23 Mylan
4.23.1 Mylan Corporation Information
4.23.2 Mylan Description, Business Overview
4.23.3 Mylan Osteoarthritis Pain Drugs Products Offered
4.23.4 Mylan Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.23.5 Mylan Osteoarthritis Pain Drugs Revenue by Product
4.23.6 Mylan Osteoarthritis Pain Drugs Revenue by Application
4.23.7 Mylan Osteoarthritis Pain Drugs Revenue by Geographic Area
4.23.8 Mylan Recent Development
4.24 Daiichi Sankyo
4.24.1 Daiichi Sankyo Corporation Information
4.24.2 Daiichi Sankyo Description, Business Overview
4.24.3 Daiichi Sankyo Osteoarthritis Pain Drugs Products Offered
4.24.4 Daiichi Sankyo Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.24.5 Daiichi Sankyo Osteoarthritis Pain Drugs Revenue by Product
4.24.6 Daiichi Sankyo Osteoarthritis Pain Drugs Revenue by Application
4.24.7 Daiichi Sankyo Osteoarthritis Pain Drugs Revenue by Geographic Area
4.24.8 Daiichi Sankyo Recent Development
4.25 TEVA
4.25.1 TEVA Corporation Information
4.25.2 TEVA Description, Business Overview
4.25.3 TEVA Osteoarthritis Pain Drugs Products Offered
4.25.4 TEVA Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.25.5 TEVA Osteoarthritis Pain Drugs Revenue by Product
4.25.6 TEVA Osteoarthritis Pain Drugs Revenue by Application
4.25.7 TEVA Osteoarthritis Pain Drugs Revenue by Geographic Area
4.25.8 TEVA Recent Development
4.26 Almatica Pharma
4.26.1 Almatica Pharma Corporation Information
4.26.2 Almatica Pharma Description, Business Overview
4.26.3 Almatica Pharma Osteoarthritis Pain Drugs Products Offered
4.26.4 Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.26.5 Almatica Pharma Osteoarthritis Pain Drugs Revenue by Product
4.26.6 Almatica Pharma Osteoarthritis Pain Drugs Revenue by Application
4.26.7 Almatica Pharma Osteoarthritis Pain Drugs Revenue by Geographic Area
4.26.8 Almatica Pharma Recent Development
4.27 Astellas Pharma
4.27.1 Astellas Pharma Corporation Information
4.27.2 Astellas Pharma Description, Business Overview
4.27.3 Astellas Pharma Osteoarthritis Pain Drugs Products Offered
4.27.4 Astellas Pharma Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.27.5 Astellas Pharma Osteoarthritis Pain Drugs Revenue by Product
4.27.6 Astellas Pharma Osteoarthritis Pain Drugs Revenue by Application
4.27.7 Astellas Pharma Osteoarthritis Pain Drugs Revenue by Geographic Area
4.27.8 Astellas Pharma Recent Development
4.28 Tide Pharmaceutical
4.28.1 Tide Pharmaceutical Corporation Information
4.28.2 Tide Pharmaceutical Description, Business Overview
4.28.3 Tide Pharmaceutical Osteoarthritis Pain Drugs Products Offered
4.28.4 Tide Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.28.5 Tide Pharmaceutical Osteoarthritis Pain Drugs Revenue by Product
4.28.6 Tide Pharmaceutical Osteoarthritis Pain Drugs Revenue by Application
4.28.7 Tide Pharmaceutical Osteoarthritis Pain Drugs Revenue by Geographic Area
4.28.8 Tide Pharmaceutical Recent Development
4.29 Iroko Pharmaceuticals
4.29.1 Iroko Pharmaceuticals Corporation Information
4.29.2 Iroko Pharmaceuticals Description, Business Overview
4.29.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Products Offered
4.29.4 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.29.5 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Revenue by Product
4.29.6 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Revenue by Application
4.29.7 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Revenue by Geographic Area
4.29.8 Iroko Pharmaceuticals Recent Development
4.30 Hengrui Pharmaceutical
4.30.1 Hengrui Pharmaceutical Corporation Information
4.30.2 Hengrui Pharmaceutical Description, Business Overview
4.30.3 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Products Offered
4.30.4 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
4.30.5 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Revenue by Product
4.30.6 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Revenue by Application
4.30.7 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Revenue by Geographic Area
4.30.8 Hengrui Pharmaceutical Recent Development
5 Breakdown Data by Type
5.1 Global Osteoarthritis Pain Drugs Sales by Type (2016-2027)
5.1.1 Global Osteoarthritis Pain Drugs Sales by Type (2016-2021)
5.1.2 Global Osteoarthritis Pain Drugs Sales Forecast by Type (2022-2027)
5.1.3 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2027)
5.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Type (2016-2027)
5.2.1 Global Osteoarthritis Pain Drugs Revenue by Type (2016-2021)
5.2.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Type (2022-2027)
5.2.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2016-2027)
5.3 Osteoarthritis Pain Drugs Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Osteoarthritis Pain Drugs Sales by Application (2016-2027)
6.1.1 Global Osteoarthritis Pain Drugs Sales by Application (2016-2021)
6.1.2 Global Osteoarthritis Pain Drugs Sales Forecast by Application (2022-2027)
6.1.3 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2027)
6.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Application (2016-2027)
6.2.1 Global Osteoarthritis Pain Drugs Revenue by Application (2016-2021)
6.2.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Application (2022-2027)
6.2.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2016-2027)
6.3 Osteoarthritis Pain Drugs Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Osteoarthritis Pain Drugs Market Size YoY Growth 2016-2027
7.2 North America Osteoarthritis Pain Drugs Market Facts & Figures by Country
7.2.1 North America Osteoarthritis Pain Drugs Sales by Country (2016-2027)
7.2.2 North America Osteoarthritis Pain Drugs Revenue by Country (2016-2027)
7.3 North America Osteoarthritis Pain Drugs Sales by Type
7.4 North America Osteoarthritis Pain Drugs Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Osteoarthritis Pain Drugs Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Osteoarthritis Pain Drugs Market Facts & Figures by Region
8.2.1 Asia-Pacific Osteoarthritis Pain Drugs Sales by Region (2016-2027)
8.2.2 Asia-Pacific Osteoarthritis Pain Drugs Revenue by Region (2016-2027)
8.3 Asia-Pacific Osteoarthritis Pain Drugs Sales by Type
8.4 Asia-Pacific Osteoarthritis Pain Drugs Sales by Application
9 Europe
9.1 Europe Osteoarthritis Pain Drugs Market Size YoY Growth 2016-2027
9.2 Europe Osteoarthritis Pain Drugs Market Facts & Figures by Country
9.2.1 Europe Osteoarthritis Pain Drugs Sales by Country (2016-2027)
9.2.2 Europe Osteoarthritis Pain Drugs Revenue by Country (2016-2027)
9.3 Europe Osteoarthritis Pain Drugs Sales by Type
9.4 Europe Osteoarthritis Pain Drugs Sales by Application
10 Latin America
10.1 Latin America Osteoarthritis Pain Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Osteoarthritis Pain Drugs Market Facts & Figures by Country
10.2.1 Latin America Osteoarthritis Pain Drugs Sales by Country (2016-2027)
10.2.2 Latin America Osteoarthritis Pain Drugs Revenue by Country (2016-2027)
10.3 Latin America Osteoarthritis Pain Drugs Sales by Type
10.4 Latin America Osteoarthritis Pain Drugs Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Osteoarthritis Pain Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Osteoarthritis Pain Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (2016-2027)
11.2.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (2016-2027)
11.3 Middle East and Africa Osteoarthritis Pain Drugs Sales by Type
11.4 Middle East and Africa Osteoarthritis Pain Drugs Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Osteoarthritis Pain Drugs Supply Chain Analysis
12.2 Osteoarthritis Pain Drugs Key Raw Materials and Upstream Suppliers
12.3 Osteoarthritis Pain Drugs Clients Analysis
12.4 Osteoarthritis Pain Drugs Sales Channel and Sales Model Analysis
12.4.1 Osteoarthritis Pain Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Osteoarthritis Pain Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Osteoarthritis Pain Drugs Distributors
13 Market Dynamics
13.1 Osteoarthritis Pain Drugs Market Drivers
13.2 Osteoarthritis Pain Drugs Market Opportunities
13.3 Osteoarthritis Pain Drugs Market Challenges
13.4 Osteoarthritis Pain Drugs Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Osteoarthritis Pain Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Oral
    Table 3. Major Manufacturers of Injection
    Table 4. Major Manufacturers of External
    Table 5. Global Osteoarthritis Pain Drugs Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 6. Global Osteoarthritis Pain Drugs Market Size by Region (US$ Million): 2021 VS 2027
    Table 7. Global Osteoarthritis Pain Drugs Sales by Region (2016-2021) & (M Dose)
    Table 8. Global Osteoarthritis Pain Drugs Sales Forecast by Region (2022-2027) & (M Dose)
    Table 9. Global Osteoarthritis Pain Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 10. Global Osteoarthritis Pain Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 11. Global Osteoarthritis Pain Drugs Sales by Manufacturer (2016-2021) & (M Dose)
    Table 12. Global Osteoarthritis Pain Drugs Sales Share by Manufacturer (2016-2021)
    Table 13. Osteoarthritis Pain Drugs Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 14. Osteoarthritis Pain Drugs Revenue Share by Manufacturer (2016-2021)
    Table 15. Key Manufacturers Osteoarthritis Pain Drugs Price (2016-2021) & (US$/Dose)
    Table 16. Ranking of Global Top Osteoarthritis Pain Drugs Manufacturers by Revenue (US$ Million) in 2020
    Table 17. Global Osteoarthritis Pain Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 18. Global Osteoarthritis Pain Drugs by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osteoarthritis Pain Drugs as of 2020)
    Table 19. Osteoarthritis Pain Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table 20. Manufacturers Osteoarthritis Pain Drugs Product Type
    Table 21. Date of International Manufacturers Enter into Osteoarthritis Pain Drugs Market
    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 23. Pfizer Corporation Information
    Table 24. Pfizer Description and Business Overview
    Table 25. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 26. Pfizer Osteoarthritis Pain Drugs Product
    Table 27. Pfizer Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 28. Pfizer Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 29. Pfizer Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 30. Pfizer Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Sales Channel
    Table 31. Pfizer Recent Development
    Table 32. Bayer Corporation Information
    Table 33. Bayer Description and Business Overview
    Table 34. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 35. Bayer Osteoarthritis Pain Drugs Product
    Table 36. Bayer Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 37. Bayer Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 38. Bayer Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 39. Bayer Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Sales Channel
    Table 40. Bayer Recent Development
    Table 41. SK Chemicals Corporation Information
    Table 42. SK Chemicals Description and Business Overview
    Table 43. SK Chemicals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 44. SK Chemicals Osteoarthritis Pain Drugs Product
    Table 45. SK Chemicals Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 46. SK Chemicals Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 47. SK Chemicals Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 48. SK Chemicals Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Sales Channel
    Table 49. SK Chemicals Recent Development
    Table 50. GSK Corporation Information
    Table 51. GSK Description and Business Overview
    Table 52. GSK Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 53. GSK Osteoarthritis Pain Drugs Product
    Table 54. GSK Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 55. GSK Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 56. GSK Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 57. GSK Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Sales Channel
    Table 58. GSK Recent Development
    Table 59. Sanofi Corporation Information
    Table 60. Sanofi Description and Business Overview
    Table 61. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 62. Sanofi Osteoarthritis Pain Drugs Product
    Table 63. Sanofi Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 64. Sanofi Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 65. Sanofi Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 66. Sanofi Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Sales Channel
    Table 67. Sanofi Recent Development
    Table 68. Crystal Genomics Corporation Information
    Table 69. Crystal Genomics Description and Business Overview
    Table 70. Crystal Genomics Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 71. Crystal Genomics Osteoarthritis Pain Drugs Product
    Table 72. Crystal Genomics Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 73. Crystal Genomics Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 74. Crystal Genomics Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 75. Crystal Genomics Recent Development
    Table 76. Johnson & Johnson Corporation Information
    Table 77. Johnson & Johnson Description and Business Overview
    Table 78. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 79. Johnson & Johnson Osteoarthritis Pain Drugs Product
    Table 80. Johnson & Johnson Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 81. Johnson & Johnson Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 82. Johnson & Johnson Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 83. Johnson & Johnson Recent Development
    Table 84. Sino Biopharmaceutical Corporation Information
    Table 85. Sino Biopharmaceutical Description and Business Overview
    Table 86. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 87. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product
    Table 88. Sino Biopharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 89. Sino Biopharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 90. Sino Biopharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 91. Sino Biopharmaceutical Recent Development
    Table 92. Haohai Biological Corporation Information
    Table 93. Haohai Biological Description and Business Overview
    Table 94. Haohai Biological Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 95. Haohai Biological Osteoarthritis Pain Drugs Product
    Table 96. Haohai Biological Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 97. Haohai Biological Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 98. Haohai Biological Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 99. Haohai Biological Recent Development
    Table 100. Zhejiang Chengyi Pharmaceutical Corporation Information
    Table 101. Zhejiang Chengyi Pharmaceutical Description and Business Overview
    Table 102. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 103. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product
    Table 104. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 105. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 106. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 107. Zhejiang Chengyi Pharmaceutical Recent Development
    Table 108. Freda Corporation Information
    Table 109. Freda Description and Business Overview
    Table 110. Freda Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 111. Freda Osteoarthritis Pain Drugs Product
    Table 112. Freda Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 113. Freda Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 114. Freda Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 115. Freda Recent Development
    Table 116. Bright Future Corporation Information
    Table 117. Bright Future Description and Business Overview
    Table 118. Bright Future Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 119. Bright Future Osteoarthritis Pain Drugs Product
    Table 120. Bright Future Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 121. Bright Future Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 122. Bright Future Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 123. Bright Future Recent Development
    Table 124. Jingfeng Pharmaceutical Corporation Information
    Table 125. Jingfeng Pharmaceutical Description and Business Overview
    Table 126. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 127. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product
    Table 128. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 129. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 130. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 131. Jingfeng Pharmaceutical Recent Development
    Table 132. Chugai Pharmaceutical Corporation Information
    Table 133. Chugai Pharmaceutical Description and Business Overview
    Table 134. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 135. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product
    Table 136. Chugai Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 137. Chugai Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 138. Chugai Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 139. Chugai Pharmaceutical Recent Development
    Table 140. Mikasa Seiyaku Corporation Information
    Table 141. Mikasa Seiyaku Description and Business Overview
    Table 142. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 143. Mikasa Seiyaku Osteoarthritis Pain Drugs Product
    Table 144. Mikasa Seiyaku Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 145. Mikasa Seiyaku Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 146. Mikasa Seiyaku Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 147. Mikasa Seiyaku Recent Development
    Table 148. Taisho Pharmaceutical Corporation Information
    Table 149. Taisho Pharmaceutical Description and Business Overview
    Table 150. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 151. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product
    Table 152. Taisho Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 153. Taisho Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 154. Taisho Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 155. Taisho Pharmaceutical Recent Development
    Table 156. Seikagaku Corporation Corporation Information
    Table 157. Seikagaku Corporation Description and Business Overview
    Table 158. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 159. Seikagaku Corporation Osteoarthritis Pain Drugs Product
    Table 160. Seikagaku Corporation Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 161. Seikagaku Corporation Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 162. Seikagaku Corporation Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 163. Seikagaku Corporation Recent Development
    Table 164. GlaxoSmithKline Corporation Information
    Table 165. GlaxoSmithKline Description and Business Overview
    Table 166. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 167. GlaxoSmithKline Osteoarthritis Pain Drugs Product
    Table 168. GlaxoSmithKline Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 169. GlaxoSmithKline Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 170. GlaxoSmithKline Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 171. GlaxoSmithKline Recent Development
    Table 172. Eli Lilly Corporation Information
    Table 173. Eli Lilly Description and Business Overview
    Table 174. Eli Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 175. Eli Lilly Osteoarthritis Pain Drugs Product
    Table 176. Eli Lilly Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 177. Eli Lilly Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 178. Eli Lilly Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 179. Eli Lilly Recent Development
    Table 180. Novartis Corporation Information
    Table 181. Novartis Description and Business Overview
    Table 182. Novartis Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 183. Novartis Osteoarthritis Pain Drugs Product
    Table 184. Novartis Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 185. Novartis Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 186. Novartis Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 187. Novartis Recent Development
    Table 188. Horizon Pharma Corporation Information
    Table 189. Horizon Pharma Description and Business Overview
    Table 190. Horizon Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 191. Horizon Pharma Osteoarthritis Pain Drugs Product
    Table 192. Horizon Pharma Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 193. Horizon Pharma Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 194. Horizon Pharma Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 195. Horizon Pharma Recent Development
    Table 196. Abbott Corporation Information
    Table 197. Abbott Description and Business Overview
    Table 198. Abbott Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 199. Abbott Osteoarthritis Pain Drugs Product
    Table 200. Abbott Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 201. Abbott Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 202. Abbott Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 203. Abbott Recent Development
    Table 204. Mylan Corporation Information
    Table 205. Mylan Description and Business Overview
    Table 206. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 207. Mylan Osteoarthritis Pain Drugs Product
    Table 208. Mylan Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 209. Mylan Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 210. Mylan Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 211. Mylan Recent Development
    Table 212. Daiichi Sankyo Corporation Information
    Table 213. Daiichi Sankyo Description and Business Overview
    Table 214. Daiichi Sankyo Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 215. Daiichi Sankyo Osteoarthritis Pain Drugs Product
    Table 216. Daiichi Sankyo Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 217. Daiichi Sankyo Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 218. Daiichi Sankyo Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 219. Daiichi Sankyo Recent Development
    Table 220. TEVA Corporation Information
    Table 221. TEVA Description and Business Overview
    Table 222. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 223. TEVA Osteoarthritis Pain Drugs Product
    Table 224. TEVA Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 225. TEVA Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 226. TEVA Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 227. TEVA Recent Development
    Table 228. Almatica Pharma Corporation Information
    Table 229. Almatica Pharma Description and Business Overview
    Table 230. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 231. Almatica Pharma Osteoarthritis Pain Drugs Product
    Table 232. Almatica Pharma Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 233. Almatica Pharma Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 234. Almatica Pharma Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 235. Almatica Pharma Recent Development
    Table 236. Astellas Pharma Corporation Information
    Table 237. Astellas Pharma Description and Business Overview
    Table 238. Astellas Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 239. Astellas Pharma Osteoarthritis Pain Drugs Product
    Table 240. Astellas Pharma Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 241. Astellas Pharma Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 242. Astellas Pharma Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 243. Astellas Pharma Recent Development
    Table 244. Tide Pharmaceutical Corporation Information
    Table 245. Tide Pharmaceutical Description and Business Overview
    Table 246. Tide Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 247. Tide Pharmaceutical Osteoarthritis Pain Drugs Product
    Table 248. Tide Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 249. Tide Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 250. Tide Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 251. Tide Pharmaceutical Recent Development
    Table 252. Iroko Pharmaceuticals Corporation Information
    Table 253. Iroko Pharmaceuticals Description and Business Overview
    Table 254. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 255. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product
    Table 256. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 257. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 258. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 259. Iroko Pharmaceuticals Recent Development
    Table 260. Hengrui Pharmaceutical Corporation Information
    Table 261. Hengrui Pharmaceutical Description and Business Overview
    Table 262. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 263. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product
    Table 264. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Product
    Table 265. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Application
    Table 266. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million) and Market Share by Geographic Area
    Table 267. Hengrui Pharmaceutical Recent Development
    Table 268. Global Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
    Table 269. Global Osteoarthritis Pain Drugs Sales Forecast by Type (2022-2027) & (M Dose)
    Table 270. Global Osteoarthritis Pain Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 271. Global Osteoarthritis Pain Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 272. Global Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
    Table 273. Global Osteoarthritis Pain Drugs Sales Forecast by Application (2022-2027) & (M Dose)
    Table 274. Global Osteoarthritis Pain Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 275. Global Osteoarthritis Pain Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 276. North America Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)
    Table 277. North America Osteoarthritis Pain Drugs Sales by Country (2022-2027) & (M Dose)
    Table 278. North America Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 279. North America Osteoarthritis Pain Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 280. North America Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
    Table 281. North America Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
    Table 282. Asia-Pacific Osteoarthritis Pain Drugs Sales by Region (2016-2021) & (M Dose)
    Table 283. Asia-Pacific Osteoarthritis Pain Drugs Sales by Region (2022-2027) & (M Dose)
    Table 284. Asia-Pacific Osteoarthritis Pain Drugs Revenue by Region (2016-2027) & (US$ Million)
    Table 285. Asia-Pacific Osteoarthritis Pain Drugs Revenue by Region (2022-2027) & (US$ Million)
    Table 286. Asia-Pacific Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
    Table 287. Asia-Pacific Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
    Table 288. Europe Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)
    Table 289. Europe Osteoarthritis Pain Drugs Sales by Country (2022-2027) & (M Dose)
    Table 290. Europe Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 291. Europe Osteoarthritis Pain Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 292. Europe Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
    Table 293. Europe Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
    Table 294. Latin America Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)
    Table 295. Latin America Osteoarthritis Pain Drugs Sales by Country (2022-2027) & (M Dose)
    Table 296. Latin America Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 297. Latin America Osteoarthritis Pain Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 298. Latin America Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
    Table 299. Latin America Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
    Table 300. Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)
    Table 301. Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (2022-2027) & (M Dose)
    Table 302. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 303. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 304. Middle East and Africa Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)
    Table 305. Middle East and Africa Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)
    Table 306. Osteoarthritis Pain Drugs Key Raw Materials, Industry Status and Trend
    Table 307. Osteoarthritis Pain Drugs Key Raw Materials and Upstream Suppliers
    Table 308. Osteoarthritis Pain Drugs Clients Status and Trend
    Table 309. Osteoarthritis Pain Drugs Typical Clients
    Table 310. Osteoarthritis Pain Drugs Distributors
    Table 311. Key Drivers: Impact Analysis (2022-2027)
    Table 312. Osteoarthritis Pain Drugs Market Drivers
    Table 313. Osteoarthritis Pain Drugs Market Opportunities
    Table 314. Osteoarthritis Pain Drugs Market Challenges
    Table 315. Osteoarthritis Pain Drugs Market Restraints
    Table 316. Osteoarthritis Pain Drugs Porter’s Five Forces Analysis
    Table 317. Research Programs/Design for This Report
    Table 318. Key Data Information from Secondary Sources
    Table 319. Key Data Information from Primary Sources
List of Figures
    Figure 1. Osteoarthritis Pain Drugs Product Picture
    Figure 2. Global Osteoarthritis Pain Drugs Sales Market Share by Type in 2021 & 2027
    Figure 3. Oral Product Picture
    Figure 4. Injection Product Picture
    Figure 5. External Product Picture
    Figure 6. Global Osteoarthritis Pain Drugs Sales Market Share by Application in 2021 & 2027
    Figure 7. Medical Care Examples
    Figure 8. Personal Care Examples
    Figure 9. Osteoarthritis Pain Drugs Report Years Considered
    Figure 10. Global Osteoarthritis Pain Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Osteoarthritis Pain Drugs Market Size 2016-2027 (US$ Million)
    Figure 12. Global Osteoarthritis Pain Drugs Sales 2016-2027 (K Units)
    Figure 13. Global Osteoarthritis Pain Drugs Market Size Market Share by Region: 2021 Versus 2027
    Figure 14. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Region (2016-2027)
    Figure 15. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2016-2027)
    Figure 16. Global Osteoarthritis Pain Drugs Sales Share by Manufacturer in 2020
    Figure 17. Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 18. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Type (2016-2027)
    Figure 19. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Type (2016-2027)
    Figure 20. Osteoarthritis Pain Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 21. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Application (2016-2027)
    Figure 22. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Application (2016-2027)
    Figure 23. Osteoarthritis Pain Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 24. North America Osteoarthritis Pain Drugs Revenue 2016-2027 (US$ Million)
    Figure 25. North America Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
    Figure 26. North America Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
    Figure 27. Asia-Pacific Osteoarthritis Pain Drugs Revenue 2016-2027 (US$ Million)
Figure 28. Asia-Pacific Ost
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

China Antipyretic Analgesics Market Report Forecast 2021 2027
China Antipyretic Analgesics Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-20T5723
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global and United States Knee Pain Management Market Size Status and Forecast 2021 2027
Global and United States Knee Pain Management Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-30J6482
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and Japan Bone Pain Treatment Market Size Status and Forecast 2021 2027
Global and Japan Bone Pain Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-6I7338
Tue Aug 24 00:00:00 UTC 2021

Add to Cart

Global Ketoprofen Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Ketoprofen Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Top 3 companies occupied about 83 market share.Market Analysis and Insights Global Ketoprofen MarketIn 2020 the global Ketoprofen market size was US 34 million and it is expected to reach US 39 million by the end of 2027 with a CAGR of 1.9 during 20212027.Global Ketoprofen Scope and Market SizeKetoprofen market is segmented by region by country company t.

120 Pages
Type: Report
Code: QYRE-Auto-2K2665
Fri Aug 13 00:00:00 UTC 2021

Add to Cart